期刊文献+

RP-HPLC法测定人肝脏微粒体中异丙酚的药物浓度 被引量:3

RP-HPLC determination of propofol concentration in human liver microsomes
下载PDF
导出
摘要 目的:建立高效液相色谱法测定人肝脏微粒体中异丙酚的药物浓度,为进一步研究异丙酚的药物代谢提供新方法,并对异丙酚的体外代谢进行初步研究。方法:异丙酚与人肝脏微粒体共孵育后用乙腈提取,采用 HP1100色谱系统,以甲醇-乙腈-双蒸水(10:50:40)为流动相,流速1.2 mL·min^(-1),进样量50 μL,经 ODS Hypersil 色谱柱(4.6 mm×250 mm,5 μm)分离,紫外检测,波长为270 nm。结果:在0.25~10 μg·mL^(-1)。浓度范围内,异丙酚线性关系良好(r=0.9992),最低检测浓度为0.02 μg·mL^(-1),定量限为0.1 μg·mL^(-1),方法回收率在95.6%~101.3%之间,日内、日间 RSD 分别为1.15%~3.23%和2.34%~7.96%。结论:本方法检测异丙酚在人肝脏微粒体中的药物浓度较为快速、准确、灵敏、稳定,适用于异丙酚的体外药代动力学研究。 Objective : To establish an RP - HPLC method for determining the concentrations of propofol in human liver microsomes, and to provide a new way for investigating the metabolism of propofol. Methods:After incubation in human liver microsomes,propofol was extracted by acetonitrile. The HP 1100 HPLC system was adopted,including a quaternary pump, a manual injector, a variable wavelength detector and a fluorescence detector. The mobile phase was a mixture of methanol- acetonitrile- water( 10: 50: 40) ,and the flow rate was 1.2 mL · min-1.50 μL of sample was injected in and separated by ODS Hypersil column(4. 6 mm × 250 mm,5 μm). The UV detector was operated at 270 nm. Results: The assay was linear over the range of 0. 25 - 10 μg·mL^-1 for propofol ( r = 0. 9992 ). The limit of detection was 0. 02 μg·mL^-1 and the limit of quantitation was 0. 1 μg·mL^-1. The method afforded recoveries was 95.6% - 101.3% , and the intra - day and inter - day RSD were 1. 15% - 3.23% and 2. 34% -7.96% ,respectively. Conclusion: The proposed method is rapid, accurate, sensitive, reliable and can be used for pharmacokinetic studies of propofol in vitro.
出处 《药物分析杂志》 CAS CSCD 北大核心 2008年第7期1060-1063,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 异丙酚 高效液相色谱 人肝脏微粒体 药物浓度 propofol HPLC human liver microsomes drug concentration
  • 相关文献

参考文献10

  • 1Favetta P, Degoute CS, Perdrix JP, et al. Propofol metabolites in man following propofol induction and maintenance. Br J Anaesth,2002, 88:653
  • 2Lang T, Klein K, Fischer J, et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics ,2001,11:399
  • 3Winters AL, Minchin FR. Modification of the Lowry assay to measure proteins and phenols in covalently bound complexes. Anal Biochem, 2005,346:43
  • 4Court MH, Duan SX, Hesse LM, et al. Cytochrome P -450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes, Anesthesiology,2001,94 : 110
  • 5Chan WH, Chen TL, Chen RM, et al. Propofol metabolism is enhanced after repetitive ketamine administration in rats: the role of cytochrome P - 4502B induction. Br J Anaesth, 2006 97 : 351
  • 6Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N - demethylation of ketamine in human liver mierosomes. Drug Metab Dispos ,2002,30:853
  • 7Mertens MJ,Vuyk J, Olofsen E, et al. Propofol alters the pharmacokinetics of alfentanil in healthy male volunteers. Anesthesiology, 2001,94:949
  • 8Inomata S,Nagashima A, Osaka Y, et al. Propofol inhibits lidocaine metabolism in human and rat liver microsomes. J Anesth, 2003,17: 246
  • 9Lee A J, Mills LH, Kosh JW, et al. NADPH - dependent metabolism of estrone by human liver microsomes. J Pharmacol Exp Ther,2002, 300 : 838
  • 10Taniguchi R, Kumai T, Matsumoto N,et al. Utilization of human liver microsomes to explain individual differences in paclitaxel metabolism by CYP2C8 and CYP3A4. J Pharmacol Sci,2005,97:83

同被引文献1960

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部